,address1,city,state,zip,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,totalDebt,quickRatio,currentRatio,returnOnAssets,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,10 High Court,Little Falls,NJ,07424,United States,973 557 8914,https://www.regenicin.com,Biotechnology,Healthcare,"Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.",3,"{'maxAge': 1, 'name': 'Mr. Randall E. McCoy', 'age': 73, 'title': 'Chairman, CEO & Pres', 'yearBorn': 1949, 'fiscalYear': 2022, 'totalPay': 250000, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0015,0.0021,0.0015,0.0015,0.0015,0.0021,0.0015,0.0015,0.0,-1.862378,83201,83201,6420,13187,13187,0.0,0.0,0,0,230224,0.0001,0.0054,0.002016,0.001616,0.0,0.0,USD,-10985166,0.0,153483008,0.18159,0.00017999999,-0.04,1664496000,1696032000,1680220800,-985391,-0.01,34:1,1280707200,PNK,EQUITY,RGIN,RGIN,REGENICIN INC,"Regenicin, Inc.",1258381800,America/New_York,EDT,-14400000,0.0015,none,11859194,0.077,642918,0.656,0.656,-0.09426,12182732,-700219,0.0,0.0,0.0,USD,
1,10 High Court,Little Falls,NJ,07424,United States,973 557 8914,https://www.regenicin.com,Biotechnology,Healthcare,"Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.",3,"{'maxAge': 1, 'name': 'Mr. John J. Weber', 'age': 72, 'title': 'CFO & Director', 'yearBorn': 1950, 'fiscalYear': 2022, 'totalPay': 125000, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0015,0.0021,0.0015,0.0015,0.0015,0.0021,0.0015,0.0015,0.0,-1.862378,83201,83201,6420,13187,13187,0.0,0.0,0,0,230224,0.0001,0.0054,0.002016,0.001616,0.0,0.0,USD,-10985166,0.0,153483008,0.18159,0.00017999999,-0.04,1664496000,1696032000,1680220800,-985391,-0.01,34:1,1280707200,PNK,EQUITY,RGIN,RGIN,REGENICIN INC,"Regenicin, Inc.",1258381800,America/New_York,EDT,-14400000,0.0015,none,11859194,0.077,642918,0.656,0.656,-0.09426,12182732,-700219,0.0,0.0,0.0,USD,
2,10 High Court,Little Falls,NJ,07424,United States,973 557 8914,https://www.regenicin.com,Biotechnology,Healthcare,"Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.",3,"{'maxAge': 1, 'name': 'Dr. J. Roy Nelson Ph.D.', 'age': 74, 'title': 'Controller & Chief Science Officer', 'yearBorn': 1948, 'fiscalYear': 2022, 'totalPay': 150000, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0015,0.0021,0.0015,0.0015,0.0015,0.0021,0.0015,0.0015,0.0,-1.862378,83201,83201,6420,13187,13187,0.0,0.0,0,0,230224,0.0001,0.0054,0.002016,0.001616,0.0,0.0,USD,-10985166,0.0,153483008,0.18159,0.00017999999,-0.04,1664496000,1696032000,1680220800,-985391,-0.01,34:1,1280707200,PNK,EQUITY,RGIN,RGIN,REGENICIN INC,"Regenicin, Inc.",1258381800,America/New_York,EDT,-14400000,0.0015,none,11859194,0.077,642918,0.656,0.656,-0.09426,12182732,-700219,0.0,0.0,0.0,USD,
